Literature DB >> 19236196

Adipokines in the treatment of diabetes mellitus and obesity.

Victoria Catalán1, Javier Gómez-Ambrosi, Amaia Rodríguez, Javier Salvador, Gema Frühbeck.   

Abstract

BACKGROUND: The physiology of adipose tissue plays a main role in the pathogenesis of type 2 diabetes mellitus. The secretion of adipocyte-derived hormones, in either an autocrine or a paracrine manner, has been proposed as a relevant mechanism in this process. In this sense, the administration and regulation of hormones derived from adipose tissue arises as an attractive option for treating metabolic disorders.
OBJECTIVE: To review the current understanding of the implication of adipokines in the development of obesity and insulin resistance, as well as their potential use as therapeutic agents.
METHODOLOGY: Review of scientific literature.
CONCLUSIONS: This review describes the role of adipokines in generating insulin resistance and the chronic low-grade inflammatory profile accompanying visceral obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19236196     DOI: 10.1517/14656560802618811

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  13 in total

Review 1.  Adiponectin, a key adipokine in obesity related liver diseases.

Authors:  Christa Buechler; Josef Wanninger; Markus Neumeier
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 2.  Transcriptional targets in adipocyte biology.

Authors:  Evan Rosen; Jun Eguchi; Zhao Xu
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

3.  Six-transmembrane epithelial antigen of prostate 4 and neutrophil gelatinase-associated lipocalin expression in visceral adipose tissue is related to iron status and inflammation in human obesity.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Fernando Rotellar; Victor Valentí; Camilo Silva; María J Gil; Javier Salvador; Gema Frühbeck
Journal:  Eur J Nutr       Date:  2012-11-22       Impact factor: 5.614

4.  Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans.

Authors:  Andoni Lancha; Rafael Moncada; Víctor Valentí; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Leire Méndez-Giménez; María J Gil; Fernando Rotellar; Secundino Fernández; Javier Salvador; Gema Frühbeck; Javier Gómez-Ambrosi
Journal:  Surg Endosc       Date:  2014-03-13       Impact factor: 4.584

5.  Identification of active miRNA and transcription factor regulatory pathways in human obesity-related inflammation.

Authors:  Xi-Mei Zhang; Lin Guo; Mei-Hua Chi; Hong-Mei Sun; Xiao-Wen Chen
Journal:  BMC Bioinformatics       Date:  2015-03-07       Impact factor: 3.169

6.  Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.

Authors:  M Gorety Jacobo-Cejudo; Roxana Valdés-Ramos; Ana L Guadarrama-López; Rosa-Virgen Pardo-Morales; Beatriz E Martínez-Carrillo; Laurence S Harbige
Journal:  Nutrients       Date:  2017-06-03       Impact factor: 5.717

7.  Specific Strains of Lactic Acid Bacteria Differentially Modulate the Profile of Adipokines In Vitro.

Authors:  Emanuel Fabersani; María Claudia Abeijon-Mukdsi; Romina Ross; Roxana Medina; Silvia González; Paola Gauffin-Cano
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

8.  A C. elegans model to study human metabolic regulation.

Authors:  Sarwar Hashmi; Yi Wang; Ranjit S Parhar; Kate S Collison; Walter Conca; Futwan Al-Mohanna; Randy Gaugler
Journal:  Nutr Metab (Lond)       Date:  2013-04-04       Impact factor: 4.169

Review 9.  Adipokines - removing road blocks to obesity and diabetes therapy.

Authors:  Matthias Blüher
Journal:  Mol Metab       Date:  2014-01-21       Impact factor: 7.422

Review 10.  Mechanisms linking excess adiposity and carcinogenesis promotion.

Authors:  Ana I Pérez-Hernández; Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.